WINDTREE THERAPEUTICS INC /DE/ Cost of Goods Sold (Deprecated 2018-01-31)
WINDTREE THERAPEUTICS INC /DE/ (WINT) reported Cost of Goods Sold (Deprecated 2018-01-31) of $0 for the 3-month period ending 2016-03-31, per its 10-Q filed 2016-05-12.
Discontinued › Expense Statement
us-gaap:CostOfGoodsSold · last filed 2017-03-31
- WINDTREE THERAPEUTICS INC /DE/ cost of goods sold (deprecated 2018-01-31) for the quarter ending 2016-03-31 was $0.00, a 100.00% decline year-over-year.
- WINDTREE THERAPEUTICS INC /DE/ cost of goods sold (deprecated 2018-01-31) for the quarter ending 2015-12-31 was $0.00, a 100.00% decline year-over-year.
- WINDTREE THERAPEUTICS INC /DE/ cost of goods sold (deprecated 2018-01-31) for the quarter ending 2015-09-30 was $0.00, a 100.00% decline year-over-year.
- WINDTREE THERAPEUTICS INC /DE/ cost of goods sold (deprecated 2018-01-31) for the quarter ending 2015-06-30 was $0.00, a 100.00% decline year-over-year.
- WINDTREE THERAPEUTICS INC /DE/ cost of goods sold (deprecated 2018-01-31) for fiscal 2015 was $929.00K, a 65.22% decline from fiscal 2014.
- WINDTREE THERAPEUTICS INC /DE/ cost of goods sold (deprecated 2018-01-31) for fiscal 2014 was $2.67M, a 416.63% increase from fiscal 2013.
- WINDTREE THERAPEUTICS INC /DE/ cost of goods sold (deprecated 2018-01-31) for fiscal 2013 was $517.00K.
- WINDTREE THERAPEUTICS INC /DE/ cost of goods sold (deprecated 2018-01-31) for fiscal 2012 was $0.00.
| Period end | Cost of Goods Sold (Deprecated 2018-01-31) 3 month | Cost of Goods Sold (Deprecated 2018-01-31) 6 month | Cost of Goods Sold (Deprecated 2018-01-31) 9 month | Cost of Goods Sold (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2016-03-31 | $0.00 10-Q · filed 2016-05-12 | $0.00 derived: sum of 2 quarters · filed 2016-05-12 | $0.00 derived: sum of 3 quarters · filed 2016-05-12 | $0.00 derived: sum of 4 quarters · filed 2016-05-12 |
| 2015-12-31 | $0.00 10-K · filed 2016-03-29 | $0.00 derived: sum of 2 quarters · filed 2016-03-29 | $0.00 derived: sum of 3 quarters · filed 2016-03-29 | $929.00K 10-K · filed 2017-03-31 |
| 2015-09-30 | $0.00 10-K · filed 2016-03-29 | $0.00 derived: sum of 2 quarters · filed 2016-03-29 | $929.00K 10-Q · filed 2016-11-14 | $1.83M derived: sum of 4 quarters · filed 2017-03-31 |
| 2015-06-30 | $0.00 10-K · filed 2016-03-29 | $929.00K 10-Q · filed 2016-08-10 | $1.83M derived: sum of 3 quarters · filed 2017-03-31 | $2.09M derived: sum of 4 quarters · filed 2017-03-31 |
| 2015-03-31 | $929.00K 10-K · filed 2017-03-31 | $1.83M derived: sum of 2 quarters · filed 2017-03-31 | $2.09M derived: sum of 3 quarters · filed 2017-03-31 | $2.82M derived: sum of 4 quarters · filed 2017-03-31 |
| 2014-12-31 | $902.00K 10-K · filed 2016-03-29 | $1.16M derived: sum of 2 quarters · filed 2016-03-29 | $1.89M derived: sum of 3 quarters · filed 2016-03-29 | $2.67M 10-K · filed 2016-03-29 |
| 2014-09-30 | $257.00K 10-K · filed 2016-03-29 | $988.00K derived: sum of 2 quarters · filed 2016-03-29 | $1.77M 10-Q · filed 2015-11-05 | $2.29M derived: sum of 4 quarters · filed 2016-03-29 |
| 2014-06-30 | $731.00K 10-K · filed 2016-03-29 | $1.51M 10-Q · filed 2015-08-10 | $2.03M derived: sum of 3 quarters · filed 2016-03-29 | $2.03M derived: sum of 4 quarters · filed 2016-03-29 |
| 2014-03-31 | $781.00K 10-K · filed 2016-03-29 | $1.30M derived: sum of 2 quarters · filed 2016-03-29 | $1.30M derived: sum of 3 quarters · filed 2016-03-29 | $1.30M derived: sum of 4 quarters · filed 2016-03-29 |
| 2013-12-31 | $517.00K 10-K · filed 2015-03-16 | $517.00K derived: sum of 2 quarters · filed 2015-03-16 | $517.00K derived: sum of 3 quarters · filed 2015-03-16 | $517.00K 10-K · filed 2015-03-16 |
| 2013-09-30 | $0.00 10-K · filed 2015-03-16 | $0.00 derived: sum of 2 quarters · filed 2015-03-16 | $0.00 10-Q · filed 2014-11-07 | |
| 2013-06-30 | $0.00 10-K · filed 2015-03-16 | $0.00 10-Q · filed 2014-08-07 | ||
| 2013-03-31 | $0.00 10-K · filed 2015-03-16 | |||
| 2012-12-31 | $0.00 10-K · filed 2015-03-16 | |||
| 2011-12-31 | $0.00 10-K · filed 2014-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |